DE60115429D1 - Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel - Google Patents

Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel

Info

Publication number
DE60115429D1
DE60115429D1 DE60115429T DE60115429T DE60115429D1 DE 60115429 D1 DE60115429 D1 DE 60115429D1 DE 60115429 T DE60115429 T DE 60115429T DE 60115429 T DE60115429 T DE 60115429T DE 60115429 D1 DE60115429 D1 DE 60115429D1
Authority
DE
Germany
Prior art keywords
dmxaa
docetaxel
combinations
paclitaxel
anticancer combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115429T
Other languages
English (en)
Other versions
DE60115429T2 (de
Inventor
Robert Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Publication of DE60115429D1 publication Critical patent/DE60115429D1/de
Application granted granted Critical
Publication of DE60115429T2 publication Critical patent/DE60115429T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60115429T 2001-08-30 2001-08-30 Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel Expired - Lifetime DE60115429T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01307370A EP1287854B1 (de) 2001-08-30 2001-08-30 Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel

Publications (2)

Publication Number Publication Date
DE60115429D1 true DE60115429D1 (de) 2006-01-05
DE60115429T2 DE60115429T2 (de) 2006-08-10

Family

ID=8182225

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115429T Expired - Lifetime DE60115429T2 (de) 2001-08-30 2001-08-30 Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel

Country Status (6)

Country Link
EP (1) EP1287854B1 (de)
AT (1) ATE311228T1 (de)
DE (1) DE60115429T2 (de)
DK (1) DK1287854T3 (de)
ES (1) ES2252160T3 (de)
SI (1) SI1287854T1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008335469A1 (en) * 2007-12-13 2009-06-18 Novartis Ag Combinations of therapeutic agents for treating cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
JP2001247459A (ja) * 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法

Also Published As

Publication number Publication date
DK1287854T3 (da) 2006-04-03
SI1287854T1 (sl) 2006-08-31
DE60115429T2 (de) 2006-08-10
ATE311228T1 (de) 2005-12-15
ES2252160T3 (es) 2006-05-16
EP1287854B1 (de) 2005-11-30
EP1287854A1 (de) 2003-03-05

Similar Documents

Publication Publication Date Title
ATE415963T1 (de) Zusammensetzungen aus dmxaa und anderen antikrebsmittel
DE60031268D1 (de) Verfahren und zusammansetzung zur behandlung von krebs
RS20080167A (en) Novel improved compositions for cancer therapy
BRPI0607017B8 (pt) composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
DE60237115D1 (de) Synergistische Kombination von (-) -Gossypol mit Docetaxel oder Paclitaxel zur Behandlung von Krebs.
NO20044259L (no) Topiske farmasoytiske sammensetninger inneholdende proantocyanidiner for behandling av dermatitt
ATE420117T1 (de) Kovalent an hyaluronsäure oder dessen derivate gebundene taxane
DE60109632D1 (de) Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
BRPI0307808A2 (pt) composição inibidora da lipase
DE69322912D1 (de) Kosmetisches und/oder Nahrungsmittel enthaltend eine nicht-verseifbare Fraktion von Sesamöl und Vitamin-E
ATE241376T1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
ATE311228T1 (de) Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxel
UY27394A1 (es) Pedidos con actividad anti- angiogéna.
PT1259502E (pt) Analogos biologicamente activos da discodermolida
ATE298328T1 (de) Taxan-derivate für die behandlung von krebs
CA2325041A1 (en) Ultra-vit. plus
DE602004017425D1 (de) Pmcol zur behandlung von prostatakrebs
BR0211762A (pt) Certos policetìdeos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores
DE60102416D1 (de) Sericin enthaltendes Mittel gegen Hautkrebs
DE602004002292D1 (de) Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase-inhibitor sowie deren verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition